These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 28753789

  • 21. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
    Kim SS, Cho YM, Kim GH, Kee KH, Kim HS, Kim KM, Kim JH, Choi C.
    Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
    [Abstract] [Full Text] [Related]

  • 22. An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers the role of focal adhesion and extracellular matrix pathways.
    Wala SJ, Karamchandani JR, Saleeb R, Evans A, Ding Q, Ibrahim R, Jewett M, Pasic M, Finelli A, Pace K, Lianidou E, Yousef GM.
    Mol Oncol; 2015 Oct; 9(8):1667-77. PubMed ID: 26051997
    [Abstract] [Full Text] [Related]

  • 23. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
    Klatte T, Pantuck AJ, Said JW, Seligson DB, Rao NP, LaRochelle JC, Shuch B, Zisman A, Kabbinavar FF, Belldegrun AS.
    Clin Cancer Res; 2009 Feb 15; 15(4):1162-9. PubMed ID: 19228721
    [Abstract] [Full Text] [Related]

  • 24. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation.
    Feng X, Zhang M, Meng J, Wang Y, Liu Y, Liang C, Fan S.
    Oncol Res; 2020 May 29; 28(3):285-297. PubMed ID: 31948514
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
    Kim M, Sohn M, Shim M, Choi SK, Park M, Kim E, Go H, Park Y, Cho YM, Ro JY, Jeong IG, Song C, Hong JH, Kim CS, Ahn H.
    Hum Pathol; 2017 Mar 29; 61():78-89. PubMed ID: 27989785
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S, You D, Jeong IG, Song C, Hong B, Hong JH, Ahn H, Kim CS.
    J Cancer Res Clin Oncol; 2017 Sep 29; 143(9):1845-1851. PubMed ID: 28451753
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
    Pang JS, Li ZK, Lin P, Wang XD, Chen G, Yan HB, Li SH.
    Oncol Rep; 2019 Apr 29; 41(4):2089-2102. PubMed ID: 30816528
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pathology, therapy and prognosis of papillary renal carcinoma.
    Fernandes DS, Lopes JM.
    Future Oncol; 2015 Apr 29; 11(1):121-32. PubMed ID: 25572787
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma.
    Wang Y, Tian X, Zhu SX, Xu WH, Anwaier A, Su JQ, Gan HL, Qu YY, Zhao JY, Zhang HL, Ye DW.
    World J Surg Oncol; 2023 Mar 16; 21(1):98. PubMed ID: 36927438
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy.
    Verbiest A, Couchy G, Job S, Caruana L, Lerut E, Oyen R, de Reyniès A, Tosco L, Joniau S, Van Poppel H, Van Raemdonck D, Van Den Eynde K, Wozniak A, Zucman-Rossi J, Beuselinck B.
    Eur Urol; 2018 Oct 16; 74(4):474-480. PubMed ID: 29463434
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.